The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 08, 2020
Filed:
Feb. 20, 2019
Applicant:
Philogen S.p.a., Siena, IT;
Inventors:
Franziska Sophie Bootz, Zürich, CH;
Dario Neri, Buchs, CH;
Assignee:
Philogen S.P.A., Siena, IT;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/54 (2006.01); A61K 38/20 (2006.01); C07K 16/18 (2006.01); C07K 19/00 (2006.01); A61K 47/68 (2017.01); C07K 16/30 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/54 (2013.01); A61K 38/20 (2013.01); A61K 47/6813 (2017.08); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); C07K 16/18 (2013.01); C07K 16/30 (2013.01); C07K 19/00 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/626 (2013.01); C07K 2319/33 (2013.01); C07K 2319/70 (2013.01);
Abstract
The application relates to a conjugate comprising interleukin-22 (IL22) and an antibody molecule. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ED-A isoform of fibronectin. In particular, the application relates to the therapeutic use of such conjugates in the treatment of a disease/disorder, such as autoimmune diseases, including inflammatory bowel disease (IBD).